Successful treatment of SARS-CoV-2 in an immunocompromised patient with persistent infection for 245 days: A case report. Author(s): Overbeck V, Taylor BP, Turcinovic J, Qiu X, Schaeffer B, Seitz S, Curry SR, Hanage WP, Connor JH, Kuppalli K|Journal: Heliyon|PMID: 38223743| December 2023 Immunocompromised patients receiving B-cell-depleting therapies are at increased risk of persistent SARS-CoV-2 infection, with many experiencing fatal outcomes. We report…
